Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients

E. M. Areman, A. Mazumder, P. L. Kotula, U. N. Verma, C. Rajagopal, S. Hancock, C. Guevarra, M. Djahanmir, R. A. Sacher, K. R. Meehan

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Patients receiving autologous transplants for various malignancies generally experience an increased incidence of relapse compared with patients receiving unmanipulated allogeneic transplants. We initiated a protocol for IL-2 activation of peripheral blood stem cells (PBSC) for induction of in vitro and in vivo autologous graft-versus-tumor (GVT) activity in patients with breast cancer. In this study we analyzed the effects of 24 h of IL-2 incubation on the hematopoietic potential of PBSC from these patients. Cells collected by leukapheresis were first cryopreserved and stored in liquid nitrogen, then thawed rapidly and incubated with IL-2 in a serum-free system for 24 h, with samples analyzed before and after incubation. Although there was a significant drop in mononuclear cells (MNC) (from 4.5 to 3.7 x 108/kg) and CD34+ cells (from 12.3 to 7.5 x 106/kg) after 24 h in culture, there was no significant change in colony-forming units (CFU) (from 12.5 to 11.5 x 105/kg). Time to engraftment (neutrophils: < 0.5 x 109/l; platelets: > 20 x 109/l) was comparable to a cohort of similar patients receiving non-cultured PBSC transplants. These results indicate that mobilized frozen/thawed PBSC which have been cultured in IL-2 for 24 h retain adequate potential for hematopoietic reconsistution in this group of patients.

Original languageEnglish (US)
Pages (from-to)521-525
Number of pages5
JournalBone Marrow Transplantation
Volume18
Issue number3
StatePublished - Sep 1996

Fingerprint

Interleukin-2
Breast Neoplasms
Transplants
Leukapheresis
Autografts
Peripheral Blood Stem Cells
Neoplasms
Neutrophils
Nitrogen
Stem Cells
Recurrence
Incidence
Serum

Keywords

  • Breast cancer
  • Immunotherapy
  • Interleukin-2
  • PBSC

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Areman, E. M., Mazumder, A., Kotula, P. L., Verma, U. N., Rajagopal, C., Hancock, S., ... Meehan, K. R. (1996). Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients. Bone Marrow Transplantation, 18(3), 521-525.

Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients. / Areman, E. M.; Mazumder, A.; Kotula, P. L.; Verma, U. N.; Rajagopal, C.; Hancock, S.; Guevarra, C.; Djahanmir, M.; Sacher, R. A.; Meehan, K. R.

In: Bone Marrow Transplantation, Vol. 18, No. 3, 09.1996, p. 521-525.

Research output: Contribution to journalArticle

Areman, EM, Mazumder, A, Kotula, PL, Verma, UN, Rajagopal, C, Hancock, S, Guevarra, C, Djahanmir, M, Sacher, RA & Meehan, KR 1996, 'Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients', Bone Marrow Transplantation, vol. 18, no. 3, pp. 521-525.
Areman EM, Mazumder A, Kotula PL, Verma UN, Rajagopal C, Hancock S et al. Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients. Bone Marrow Transplantation. 1996 Sep;18(3):521-525.
Areman, E. M. ; Mazumder, A. ; Kotula, P. L. ; Verma, U. N. ; Rajagopal, C. ; Hancock, S. ; Guevarra, C. ; Djahanmir, M. ; Sacher, R. A. ; Meehan, K. R. / Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients. In: Bone Marrow Transplantation. 1996 ; Vol. 18, No. 3. pp. 521-525.
@article{453cfd1cb3d04a829015048f15ecf90e,
title = "Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients",
abstract = "Patients receiving autologous transplants for various malignancies generally experience an increased incidence of relapse compared with patients receiving unmanipulated allogeneic transplants. We initiated a protocol for IL-2 activation of peripheral blood stem cells (PBSC) for induction of in vitro and in vivo autologous graft-versus-tumor (GVT) activity in patients with breast cancer. In this study we analyzed the effects of 24 h of IL-2 incubation on the hematopoietic potential of PBSC from these patients. Cells collected by leukapheresis were first cryopreserved and stored in liquid nitrogen, then thawed rapidly and incubated with IL-2 in a serum-free system for 24 h, with samples analyzed before and after incubation. Although there was a significant drop in mononuclear cells (MNC) (from 4.5 to 3.7 x 108/kg) and CD34+ cells (from 12.3 to 7.5 x 106/kg) after 24 h in culture, there was no significant change in colony-forming units (CFU) (from 12.5 to 11.5 x 105/kg). Time to engraftment (neutrophils: < 0.5 x 109/l; platelets: > 20 x 109/l) was comparable to a cohort of similar patients receiving non-cultured PBSC transplants. These results indicate that mobilized frozen/thawed PBSC which have been cultured in IL-2 for 24 h retain adequate potential for hematopoietic reconsistution in this group of patients.",
keywords = "Breast cancer, Immunotherapy, Interleukin-2, PBSC",
author = "Areman, {E. M.} and A. Mazumder and Kotula, {P. L.} and Verma, {U. N.} and C. Rajagopal and S. Hancock and C. Guevarra and M. Djahanmir and Sacher, {R. A.} and Meehan, {K. R.}",
year = "1996",
month = "9",
language = "English (US)",
volume = "18",
pages = "521--525",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients

AU - Areman, E. M.

AU - Mazumder, A.

AU - Kotula, P. L.

AU - Verma, U. N.

AU - Rajagopal, C.

AU - Hancock, S.

AU - Guevarra, C.

AU - Djahanmir, M.

AU - Sacher, R. A.

AU - Meehan, K. R.

PY - 1996/9

Y1 - 1996/9

N2 - Patients receiving autologous transplants for various malignancies generally experience an increased incidence of relapse compared with patients receiving unmanipulated allogeneic transplants. We initiated a protocol for IL-2 activation of peripheral blood stem cells (PBSC) for induction of in vitro and in vivo autologous graft-versus-tumor (GVT) activity in patients with breast cancer. In this study we analyzed the effects of 24 h of IL-2 incubation on the hematopoietic potential of PBSC from these patients. Cells collected by leukapheresis were first cryopreserved and stored in liquid nitrogen, then thawed rapidly and incubated with IL-2 in a serum-free system for 24 h, with samples analyzed before and after incubation. Although there was a significant drop in mononuclear cells (MNC) (from 4.5 to 3.7 x 108/kg) and CD34+ cells (from 12.3 to 7.5 x 106/kg) after 24 h in culture, there was no significant change in colony-forming units (CFU) (from 12.5 to 11.5 x 105/kg). Time to engraftment (neutrophils: < 0.5 x 109/l; platelets: > 20 x 109/l) was comparable to a cohort of similar patients receiving non-cultured PBSC transplants. These results indicate that mobilized frozen/thawed PBSC which have been cultured in IL-2 for 24 h retain adequate potential for hematopoietic reconsistution in this group of patients.

AB - Patients receiving autologous transplants for various malignancies generally experience an increased incidence of relapse compared with patients receiving unmanipulated allogeneic transplants. We initiated a protocol for IL-2 activation of peripheral blood stem cells (PBSC) for induction of in vitro and in vivo autologous graft-versus-tumor (GVT) activity in patients with breast cancer. In this study we analyzed the effects of 24 h of IL-2 incubation on the hematopoietic potential of PBSC from these patients. Cells collected by leukapheresis were first cryopreserved and stored in liquid nitrogen, then thawed rapidly and incubated with IL-2 in a serum-free system for 24 h, with samples analyzed before and after incubation. Although there was a significant drop in mononuclear cells (MNC) (from 4.5 to 3.7 x 108/kg) and CD34+ cells (from 12.3 to 7.5 x 106/kg) after 24 h in culture, there was no significant change in colony-forming units (CFU) (from 12.5 to 11.5 x 105/kg). Time to engraftment (neutrophils: < 0.5 x 109/l; platelets: > 20 x 109/l) was comparable to a cohort of similar patients receiving non-cultured PBSC transplants. These results indicate that mobilized frozen/thawed PBSC which have been cultured in IL-2 for 24 h retain adequate potential for hematopoietic reconsistution in this group of patients.

KW - Breast cancer

KW - Immunotherapy

KW - Interleukin-2

KW - PBSC

UR - http://www.scopus.com/inward/record.url?scp=10144253708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10144253708&partnerID=8YFLogxK

M3 - Article

C2 - 8879612

AN - SCOPUS:10144253708

VL - 18

SP - 521

EP - 525

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 3

ER -